Future Science OA

Scope & Guideline

Advancing knowledge in biotechnology and medicine.

Introduction

Explore the comprehensive scope of Future Science OA through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Future Science OA in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN2056-5623
PublisherFUTURE SCI LTD
Support Open AccessYes
CountryUnited Kingdom
TypeJournal
Convergefrom 2015 to 2024
AbbreviationFUTUR SCI OA / Futur. Sci. OA
Frequency10 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressUNITED HOUSE, 2 ALBERT PL, LONDON N3 1QB, ENGLAND

Aims and Scopes

The journal 'Future Science OA' aims to publish high-quality, peer-reviewed research that contributes to the advancement of knowledge across various scientific disciplines, particularly in health sciences, biomedical research, and pharmacology. Its scope encompasses a wide range of topics, methodologies, and innovative approaches to address contemporary challenges in healthcare and medicine.
  1. Translational Medicine and Clinical Research:
    Focuses on bridging laboratory research and clinical practice, emphasizing studies that translate findings into real-world healthcare solutions.
  2. Innovative Therapeutics and Drug Development:
    Covers research on new therapeutic agents, drug delivery systems, and novel treatment strategies for various diseases, highlighting advancements in pharmacology and biotechnology.
  3. Public Health and Epidemiology:
    Addresses public health issues, disease prevalence, and the impact of social determinants on health, with a strong emphasis on community health interventions and epidemiological studies.
  4. Artificial Intelligence and Computational Biology:
    Explores the integration of AI and machine learning into biomedical research, including drug discovery, diagnostics, and personalized medicine.
  5. Cancer Research and Oncology:
    Includes studies on cancer biology, treatment modalities, prognosis, and innovative therapies, reflecting a commitment to combat cancer through research.
  6. Immunology and Infectious Diseases:
    Investigates immune responses, vaccine development, and the pathogenesis of infectious diseases, including the impact of recent pandemics.
Recent publications in 'Future Science OA' exhibit a clear trend towards emerging themes that reflect current challenges and advancements in the scientific community. These themes not only highlight innovative research but also respond to global health crises and technological advancements.
  1. COVID-19 Research and Its Implications:
    A significant increase in research related to COVID-19, including vaccine development, epidemiology, and long-term effects, demonstrating the journal's responsiveness to ongoing global health challenges.
  2. Integrative Approaches in Health Sciences:
    Growing emphasis on interdisciplinary research that combines various fields such as genetics, microbiology, and public health to address complex health issues.
  3. Personalized Medicine and Genomics:
    A surge in studies focusing on personalized medicine, including genetic profiling and tailored therapeutic strategies, reflecting advancements in genomic technologies.
  4. Nanotechnology and Drug Delivery Systems:
    Emerging interest in nanotechnology applications for drug delivery and therapeutic interventions, indicating a shift towards innovative and efficient treatment modalities.
  5. Mental Health and Psychosocial Aspects of Disease:
    Increasing focus on the psychological impact of diseases, particularly in the context of chronic illnesses and the effects of the COVID-19 pandemic on mental health.

Declining or Waning

Over the past few years, certain research themes within 'Future Science OA' have shown a decline in publication frequency, indicating a shift in focus towards more contemporary and pressing scientific inquiries.
  1. Traditional Pharmacology Studies:
    There has been a noticeable reduction in the publication of studies focused solely on traditional pharmacology without the integration of novel therapeutic approaches or technologies.
  2. Basic Science Research without Clinical Application:
    Research papers that focus exclusively on basic science without a clear translational aspect or clinical relevance appear to be waning, reflecting a preference for studies that can be applied in real-world settings.
  3. Single-Disease Focus Studies:
    The journal is moving away from studies that concentrate on single diseases without considering comorbidities or broader health implications, favoring interdisciplinary approaches that consider multiple health factors.

Similar Journals

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Empowering knowledge in cardiovascular therapies since 1979.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0160-2446Frequency: 12 issues/year

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, published by LIPPINCOTT WILLIAMS & WILKINS, is a leading peer-reviewed journal dedicated to the exploration and advancement of pharmacological therapies related to cardiovascular diseases. With its ISSN 0160-2446 and E-ISSN 1533-4023, this esteemed journal has been at the forefront of cardiovascular research since its inception in 1979, continuously offering insights until 2024. It holds a commendable position in the 2023 category quartiles, classified as Q2 in both Cardiology and Cardiovascular Medicine, as well as Medicine (miscellaneous) and Pharmacology, showcasing its significance within these fields. The journal presents a unique platform for researchers, health professionals, and students to disseminate their findings, fostering an environment of knowledge growth and collaboration in cardiovascular pharmacology. Readers can expect to find high-quality articles that contribute to the body of knowledge in cardiovascular therapies, ensuring they remain informed of the latest advancements and clinical practices. Discover more about this influential publication and its commitment to enhancing cardiovascular health.

BioScience Trends

Elevating Scientific Dialogue in Biochemical Research
Publisher: IRCA-BSSAISSN: 1881-7815Frequency: 6 issues/year

BioScience Trends, published by IRCA-BSSA, is a leading academic journal based in Japan that significantly contributes to the fields of biochemistry, genetics, molecular biology, and social health sciences. With an impactful Scopus ranking that places it in the 97th percentile for health social sciences and the 89th percentile for general biochemistry, this journal is an essential resource for researchers and professionals alike. Since its inception in 2007, BioScience Trends has fostered high-quality research dissemination and collaboration, offering a platform for innovative studies and insights that are vital for advancing knowledge in life sciences. Despite being a non-open access publication, it maintains rigorous standards and a reputable presence in the academic community, with an impressive categorization into Q1 and Q2 quartiles as of 2023. Researchers, students, and professionals seeking to stay at the forefront of scientific exploration and health advancements will find BioScience Trends to be an invaluable source for scholarly articles and emerging trends in their respective fields.

New Armenian Medical Journal

Shaping the Future of Medicine Through Rigorous Research.
Publisher: YEREVAN STATE MEDICAL UNIVISSN: 1829-0825Frequency: 4 issues/year

New Armenian Medical Journal (ISSN: 1829-0825, E-ISSN: 1829-0825) is a prominent academic publication established by Yerevan State Medical University, dedicated to advancing the field of medicine through high-quality research and scholarly discourse. Located in Armenia, this journal serves as a vital platform for disseminating innovative findings and clinical practices, with a particular focus on the regional healthcare landscape as well as global health issues. While currently categorized in the lower quartile (Q4) of general medicine, it demonstrates a commitment to improving its impact factor and ranking, evidenced by its ongoing publication from 2009 to 2024. The journal embraces a diverse scope that encompasses miscellaneous topics within medical research, catering to the needs of practitioners, researchers, and students alike. Though not an open-access journal, it offers valuable insights and knowledge that contribute meaningfully to the medical community. By participating in this scholarly dialogue, readers can enhance their understanding and foster advancements in the ever-evolving field of medicine.

JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES

Exploring the frontiers of pharmacy and science.
Publisher: FRONTIERS MEDIA SAISSN: Frequency: 1 issue/year

Welcome to the JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, a prestigious open access journal published by FRONTIERS MEDIA SA since 2008, dedicated to advancing research in the fields of pharmacy and pharmaceutical sciences. With its strong rooting in Canada, this journal has established itself within the academic community by consistently delivering high-quality studies and insights, as evidenced by its respectable Q2 ranking in both Medicine (miscellaneous) and Pharmaceutical Science categories for 2023, along with a notable 77th percentile ranking in Pharmaceutical Science on Scopus. Spanning over two decades of publication from 1998 to 2024, the journal focuses on critical research areas including pharmacology, toxicology, and drug development. By providing open access to its articles, the journal ensures that vital scientific information is readily available to researchers, professionals, and students alike, fostering collaboration and innovation within these essential disciplines. We invite you to explore the latest findings and contribute to the ongoing dialogue in pharmaceutical research through this essential platform.

Global Journal of Medical Pharmaceutical and Biomedical Update

Empowering Knowledge in Medicine and Biomedical Sciences
Publisher: SCIENTIFIC SCHOLAR LLCISSN: Frequency: 1 issue/year

Global Journal of Medical Pharmaceutical and Biomedical Update, published by SCIENTIFIC SCHOLAR LLC, is a premier platform dedicated to advancing knowledge in the fields of medicine, pharmaceuticals, and biomedical sciences. With an E-ISSN of 2765-8910, this journal aims to foster innovative research and insightful discussions by providing open access to high-quality peer-reviewed articles. It serves as an invaluable resource for researchers, professionals, and students alike, ensuring that the latest advancements, methodologies, and findings are accessible to a diverse audience. Located at 50, Woodgreen Dr, Pittsford, NY 14534, the journal prioritizes the dissemination of critical information that addresses the evolving challenges faced in healthcare and biomedical research, ultimately contributing to the betterment of global health outcomes.

JCPSP-Journal of the College of Physicians and Surgeons Pakistan

Advancing medical knowledge for a healthier tomorrow.
Publisher: COLL PHYSICIANS & SURGEONS PAKISTANISSN: 1022-386XFrequency: 12 issues/year

Welcome to the JCPSP-Journal of the College of Physicians and Surgeons Pakistan, a pivotal platform for advancing knowledge in the field of medicine. Published by the College of Physicians and Surgeons Pakistan, this distinguished journal, with the ISSN 1022-386X and E-ISSN 1681-7168, has been disseminating critical research and clinical insights since 1996. With a focus on various realms of general medicine and holding a current Scopus rank of #291 out of 636, the JCPSP is classified in the Q3 quartile for miscellaneous medicine, indicating its growing influence and expertise. The journal aims to foster scholarly communication and collaboration among healthcare professionals, researchers, and students in Pakistan and beyond, enhancing clinical practice and medical education. Although it does not currently offer Open Access, its curated content and comprehensive research articles are essential for those engaged in the medical sciences. Join us in exploring the latest findings and contributions impacting the healthcare landscape in Pakistan and worldwide.

Med

Empowering the Global Medical Community with Knowledge.
Publisher: CELL PRESSISSN: 2666-6340Frequency: 12 issues/year

Med, an esteemed journal published by CELL PRESS, stands at the forefront of interdisciplinary medical research, making significant contributions to the field of Medicine since its inception in 2020. With an impressive Q1 ranking in the Medicine (miscellaneous) category and a notable 96th percentile ranking in General Medicine according to Scopus, this journal is dedicated to disseminating high-quality research that advances medical knowledge and practice. Med provides a platform where researchers, professionals, and students can share their findings and insights, fostering a collaborative environment that bridges various aspects of medicine. While offering a comprehensive body of research, Med is committed to promoting open communication within the scientific community, ensuring that valuable information is accessible to those who seek to enhance their understanding and application of medical science. With a strong presence in the United States and a global readership, Med is poised to influence the future of healthcare significantly.

Cukurova Medical Journal

Advancing Medicine Through Open Access Innovation
Publisher: CUKUROVA UNIV, FAC MEDICINEISSN: 2602-3032Frequency: 4 issues/year

Cukurova Medical Journal is a distinguished open-access publication specializing in the field of medicine, dedicated to advancing the exchange of knowledge and research findings since its inception in 2011. Published by Cukurova University, Faculty of Medicine, this journal features a diverse array of peer-reviewed articles that cater to a global readership of researchers, healthcare professionals, and students striving to stay informed about the latest developments in medical science. With its commitment to accessibility, Cukurova Medical Journal facilitates the dissemination of critical research without barriers, empowering scholars and practitioners to enhance their understanding and contribute to the field. While specific metrics such as HIndex and Scopus ranks are currently unavailable, the journal aims to achieve high academic standards and impact within the medical community. Based in Adana, Türkiye, the journal also embraces a rich cultural context, fostering innovative research and collaboration across borders.

Biomolecules and Biomedicine

Exploring the Molecular Basis of Life and Disease
Publisher: ASSOC BASIC MEDICAL SCI FEDERATION BOSNIA & HERZEGOVINA SARAJEVOISSN: 2831-0896Frequency: 6 issues/year

Biomolecules and Biomedicine is a pioneering open-access journal dedicated to advancing the fields of molecular biology and biomedical sciences, published by the Association of Basic Medical Science Federation Bosnia & Herzegovina in Sarajevo. With the ISSN 2831-0896 and the E-ISSN 2831-090X, this journal aims to facilitate the dissemination of high-quality research from 2023 onwards, inviting submissions that provide innovative insights and findings across various facets of medicine and biological sciences. Positioned within the General Medicine and Biochemistry, Genetics and Molecular Biology categories, it currently holds rankings of 332 out of 636 and 173 out of 221 respectively, highlighting its emerging influence in these fields. As an open-access journal, it ensures that all published research is freely accessible to a global audience, fostering collaboration and knowledge exchange among researchers, professionals, and students alike. With a commitment to enhancing scientific discourse and promoting cutting-edge research, Biomolecules and Biomedicine is poised to become a vital resource for those dedicated to unraveling the complexities of biomolecules and their roles in health and disease.

Biomedical Reports

Advancing knowledge in the heart of biomedical sciences.
Publisher: SPANDIDOS PUBL LTDISSN: 2049-9434Frequency: 6 issues/year

Biomedical Reports, published by SPANDIDOS PUBL LTD in Greece, is a distinguished open-access journal that focuses on the dynamic fields of biochemistry, genetics, molecular biology, medicine, pharmacology, and neuroscience. Established in 2014, the journal has rapidly gained recognition, securing Q2 and Q3 rankings in several categories for 2023, including a notable ranking of #125/636 in General Medicine, placing it in the 80th percentile amongst its peers. The journal continually aims to disseminate innovative research findings that advance the understanding of complex biomedical issues, making it an invaluable resource for researchers, professionals, and students alike. Its multidisciplinary approach not only reflects the interconnectivity of modern biomedical sciences but also promotes collaborative discourse among diverse fields, ensuring ongoing relevance and impact within the scientific community.